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estimation of intracardiac shunts 
in young children with a novel 
indicator dilution technology
theodor Skuli Sigurdsson  1,2* & Lars Lindberg1
clinical evaluation of intracardiac shunts in children is not straightforward. echocardiography can only 
diagnose the presence of a shunt but does not estimate the shunt ratio. this can be a critical factor that 
influences treatment options. In this single-center, prospective, observational, method-comparison 
study, we validate the ability of a novel monitoring device COstatus to estimate the intracardiac 
shunt ratio (Qp/Qs) of pulmonary (Qp) to systemic (Qs) blood flow in young children before and after 
corrective cardiac surgery. the indicator dilution technology costatus monitor was compared to two 
other more invasive reference techniques, perivascular ultrasonic flow probes (placed around the 
pulmonary truncus and ascending aorta) and the oximetric shunt equation (using arterial and venous 
blood gases). our study revealed that the costatus monitor detected intracardiac shunts with high 
sensitivity and specificity but there was some underestimation of the shunt ratios compared to the 
reference techniques.
Clinical evaluation of critically ill children by physicians is often imprecise and can lead to an unreliable estima-
tion of the true hemodynamic condition1–5. A reliable hemodynamic monitoring device that is safe and easily 
adapted in children would be beneficial to guide physicians in clinical decisions6–8. The diagnosis and evalu-
ation of an intracardiac shunt in a critically ill child is also important in regards to treatment, as undiagnosed 
congenital heart disease with intracardiac shunt has been associated with significant morbidity9. In left-to-right 
shunts, cardiac defects at the atrial level (atrial septal defects and anomalous pulmonary venous drainage) cause 
oxygen-saturated blood to reenter the pulmonary circulation resulting in increased right heart volume load. 
On the other hand, cardiac defects at the ventricular or great artery level (ventricular septal defects, patent arte-
rial duct and aortopulmonary collaterals) may cause either left heart volume overload or a combination of left 
heart volume and right heart pressure overload (depending on the size of the defect). In right-to-left shunts, 
oxygen-desaturated blood bypasses the pulmonary circulation and causes arterial desaturation. This can be seen 
in children with large intracardiac defects, where saturated and desaturated blood is mixed, in children with atrial 
septal defects with high central venous pressure or in children with ventricular septal defects with high right ven-
tricular pressure, such as those with pulmonary hypertension. The difference in pulmonary (Qp) and aortic blood 
flow (Qs) is one of the variables used to estimate the size of intracardiac shunts (by calculating the Qp/Qs ratio) as 
a determination of clinical significance and indication for surgical correction (Table 1).
The methods used to determine the Qp/Qs ratio are usually highly invasive and require general anesthesia. 
In the catheterization laboratory, it is possible to retrieve blood gases from arterial and mixed venous blood and 
use the oximetric shunt formula to calculate a Qp/Qs ratio. There are non-invasive methods to diagnose intra-
cardiac shunts available, but they are imprecise and have clinical limitations10. Echocardiography has become the 
method of choice to detect the presence of intracardiac shunts but is not accurate in determining the Qp/Qs ratio. 
Magnetic resonance imaging can estimate the Qp/Qs ratio but is impractical in critically ill children and is time 
consuming.
COstatus (Transonic Systems Inc, Ithaca, NY, USA) is a novel monitoring device that can detect shunts and 
estimate the Qp/Qs ratio by analyzing transcardiopulmonary blood dilution with saline detected by ultrasound 
sensors11. The technique is also able to determine cardiac output, total end-diastolic cardiac volume, central 
blood volume and active circulation blood volume, all of which can be of value in the evaluation of a critically ill 
child12–17.
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The primary aim of this study was to determine how accurate COstatus was in discriminating between the 
presence of a shunt and no shunt. The secondary aim was to compare the Qp/Qs ratio of the intracardiac shunts 
calculated by COstatus with two other methodologically different reference techniques. With the use of perivas-
cular ultrasonic transit time flow probes placed around the pulmonary truncus and aorta, the pulmonary blood 
flow (Qp) and aortic blood flow (Qs) could be simultaneously measured to determine the Qp/Qs ratio. The Qp/
Qs ratio was also calculated by the oximetric shunt formula using collected arterial and venous blood gases.
Results
A total of forty-four children were included in the study. The mean age of the patients was 12 months (range 1 to 
43 months), and the mean weight was 7.1 kg (range 2.7 to 13.6 kg). The surgeon was not able to place the perivas-
cular flow probe in one child without compromising circulatory stability, resulting in 215 paired COstatus and 
perivascular flow probe estimations (PVFP) of Qp/Qs ratios (five for each child) and 44 consecutive oximetric 
shunt equation (OSE) calculations of Qp/Qs ratios before and after the surgical correction (estimated mean Qp/
Qs ratios are shown in Table 2).
COstatus detected a Qp/Qs ratio of >1.0 in 43 out of 44 patients with a transesophageal echocardiography 
(TEE) confirmed defect before the surgical correction. In 2 out of 44 patients, COstatus detected an intracardiac 
bidirectional shunt. These two patients were excluded from the comparison of left-to-right shunts between the 
techniques.
QP/QS Shunt type
<1.0 Right-to-left shunt
1.0 No shunt
1.0 < x < 1.5 Small left-to-right shunt
1.5 ≤ x < 2.0 Moderate left-to-right shunt
≥2.0 Large left-to-right shunt
Table 1. Definition of shunts depending on the quotient or ratio between the blood flow in pulmonary 
circulation (QP) and systemic circulation (QS): Qp/Qs.
Patient Defect
Qp/Qs
Patient Defect
Qp/Qs
COstatus PVFP OSE COstatus PVFP OSE
1 ASD/VSD BD 2.0 1.4 23 ASD >2 4.9 4.2
2 VSD >2 2.4 2.9 24 ASD 1–1.5 4.3 2.9
3 VSD >2 3.2 3.9 25 VSD >2 3.5 3.7
4 ASD >2 M 7.3 26 ASD/VSD >2 9.7 10.0
5 ASD >2 3.4 3.9 27 ASD/VSD >2 3.9 2.9
6 VSD 1.5–2 2.8 2.4 28 ASD >2 3.8 2.3
7 VSD 1–1.5 3.6 3.0 29 VSD >2 2.0 3.3
8 VSD 1.5–2 3.6 2.9 30 VSD 1.5–2 2.0 4.5
9 VSD 1–1.5 3.2 2.5 31 VSD >2 3.0 2.5
10 VSD 1.5–2 3.6 3.8 32 ASD/VSD >2 1.9 3.5
11 VSD 1.5–2 2.6 3.9 33 ASD/VSD >2 2.4 2.4
12 VSD 1.5–2 2.3 2.6 34 VSD 1–1.5 1.6 1.5
13 VSD 1.5–2 3.0 4.4 35 ASD 1–1.5 2.1 1.1
14 ASD >2 2.6 2.0 36 VSD 1–1.5 1.8 1.4
15 VSD >2 3.9 3.7 37 VSD 1–1.5 1.3 1.4
16 ASD >2 1.6 2.3 38 VSD >2 4.6 3.2
17 VSD 1.5–2 2.8 4.5 39 ASD/VSD >2 2.1 1.4
18 ASD 1 1.7 1.3 40 ASD/VSD >2 3.4 2.8
19 ASD >2 3.1 2.4 41 ASD/VSD >2 1.8 2.5
20 VSD 1–1.5 1.4 1.7 42 ASD BD 3.1 2.7
21 VSD 1.5–2 2.4 3.0 43 VSD 1–1.5 1.0 2.0
22 ASD/VSD 1.5–2 4.3 4.3 44 VSD 1–1.5 1.3 3.1
Table 2. Estimated mean Qp/Qs ratios by COstatus (n = 5), perivascular flow probes (n = 5) and oximetric 
calculations (n = 1) before the surgical correction. PVFP = perivascular flow probe, OSE = oximetric shunt 
equation. ASD = atrial septal defect, VSD = ventricular septal defect. BD = bidirectional shunt, M = missing 
value.
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The mean Qp/Qs PVFP was 2.9 ± 1.2 (range 1.0 to 9.7), and the mean Qp/Qs OSE was 3.0 ± 1.6 (range 1.1 to 
10.0). The bias between Qp/Qs PVFP vs Qp/Qs OSE was 0.07 using Bland-Altman analysis (LOA ± 1.84), while the 
percentage error between Qp/Qs PVFP vs Qp/Qs OSE was 58.8%.
Three very small residual defects were detected by color flow doppler signals of the TEE after surgical correc-
tion. Two of them were also indicated by Qp/Qs ratios >1.0 by COstatus. In addition, COstatus also indicated a 
small residual shunt in another patient (supported by the oximetric Qp/Qs calculation) but not detected by the 
color flow doppler of the TEE. This resulted in a sensitivity of 95.7% (95% CI: 85.5% to 99.5%) and specificity of 
97.6% (95% CI: 87.1% to 99.9%) for COstatus to discriminate between intracardiac left-to-right shunt and no 
shunt. The area under the receiver operating characteristic (ROC) curve was 0.97 to diagnose an intracardiac 
left-to-right shunt (Fig. 1).
The categorized Qp/Qs ratios estimated by COstatus showed a statistically significant underestimation 
(p < 0.05) for the Qp/Qs ratios in moderate and small shunt size groups compared with Qp/Qs determined by the 
perivascular flow probes and those calculated by the oximetric shunt equation (Fig. 2). Since COstatus only gives 
a value of Qp/Qs ratio >2 in the large shunt size group (shown in Table 2) it is not possible to comment on the 
exact accuracy compared with the other techniques in the large shunt size group.
Discussion
In the present study, we found that the COstatus monitoring device detects intracardiac left-to-right shunts in 
most cases, but there was some underestimation regarding shunt ratios compared to the reference methods.
Our results agree with earlier studies that have compared COstatus with oximetric calculation of the Qp/Qs 
ratio during cardiac catheterization and in an animal model, in which COstatus detects intracardiac left-to-right 
shunt with high sensitivity and specificity18,19. The specificity in this study was probably higher than in the article 
by Saxena et al., due to a high number of tiny intracardiac left-to-right shunts of no clinical significance unde-
tected by echocardiography in their study15. The incidence of residual shunt after surgical correction was low and 
only detected in 3 patients (7%) by postoperative TEE. These very small intracardiac left-to-right shunts were all 
Figure 1. Comparison between COstatus and transesophageal echocardiography for detecting and excluding a 
left-to-right shunt and an ROC curve showing accuracy for diagnosing a left-to-right shunt.
Figure 2. Comparison between categorized groups of Qp/Qs ratios of COstatus and Qp/Qs ratios estimated 
by perivascular flow probes around the pulmonary truncus and aorta (A) and Qp/Qs ratios calculated by the 
oximetric shunt equation from blood gas analysis. (B) The vertical bars contain 95% confidence intervals in 
each categorized shunt group (*indicates P < 0.05).
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considered clinically insignificant. In one case, the COstatus was unable to detect a left-to-right blood flow (only 
detected in one out of five measurements), although it was observed by the color flow doppler. Sometimes the 
pressure gradient between the atrium may be low and varying in time, making the blood flow across the septum 
minimal and therefore difficult to detect by dilution technology. On the other hand, COstatus detected a very 
small left-to-right blood flow together with the oximetric calculation, which was not observed by the TEE, indi-
cating a high degree of sensitivity for detection of intracardiac left-to-right shunts, even those that were clinically 
insignificant or difficult to detect by echocardiography.
There was a statistically significant underestimation of the shunt ratio as shown in Fig. 2 in moderate and 
small shunt size groups in this study compared to the reference methods. Although Fig. 2 seems to show a good 
agreement between all methods in the large shunt size group, Table 2 reveals that COstatus only indicates a large 
shunt with a Qp/Qs ratio >2 which makes it difficult to interpret shunt accuracy between methods in the large 
shunt size group. This underestimation might partly be explained by Transonic’s approach in formulation of the 
algorithm to calculate the shunt ratio. The perivascular flow probe around the ascending aorta does not include 
the coronary blood flow and may therefore give a slightly to low Qs and thus an inaccurate high Qp/Qs ratio. The 
shape of the dilution curve is dependent on heart rate, ventricular function and peripheral resistance, which may 
cause difficulties in the formulation of a general algorithm for all ages, ventricular functions, shunt sizes and level 
of blood volumes. Our results might hint that a possible improvement of the algorithm may be needed for shunt 
ratio determination in this young age group. This underestimation is in contrast with earlier studies, where shunt 
estimation with dilution methods have overestimated the Qp/Qs ratios in children compared with oximetric 
techniques20–23. The overestimation of Qp in these studies may be caused by the rapid systemic recirculation that 
occurs in children. This resulted from the technique that was used at the time to determine the area under curve 
(AUC) providing an inaccurate overestimation of the AUC, which reflects Qp. In adults, the oximetric technique 
has provided Qp/Qs shunt estimates that were larger than the dilution technique, which is in agreement with our 
findings24. The estimation of Qp/Qs by the oximetric technique agreed well with the estimation made by the flow 
probes with only a difference of 0.07 in mean Qp/Qs ratio but with a relative high percentage error (58.8%). Direct 
blood gas measurements included in the oximetric shunt equation involved calculating venous oxygen saturation 
by adding three times the oxygenation saturation in the superior vena cava with saturation in the inferior vena 
cava and dividing the sum by four (Flamm’s formula). This could result in a false low estimation of venous oxygen 
saturation, explaining possible differences between methods. An alternative explanation for the disagreement 
between methods is that equilibrium between the oxygen uptake and the oxygen consumption did not exist. The 
quantification of Qp/Qs ratios may be of value to determine the need for surgical correction. However, since 
COstatus presents intracardiac left-to-right shunts as a range value in accordance with clinical significance, it was 
difficult to perform a true validation of how well the Qp/Qs ratios were estimated or how large the shunt actually 
was in compared with the other methods.
One limitation of the study is that it was technically impossible to have two flow probes placed around both 
the ascending aorta and the pulmonary truncus in the infants at the same time as it affected the blood flow in 
the large vessels and coronaries. Another important limitation is that the aortic flow probe reading does not 
account for the myocardial blood flow and thus always underestimates systemic blood flow (Qs). The amount of 
coronary blood flow is uncertain but has been claimed to be approximately 7% (probably higher in a heart with a 
left-to-right shunt due to myocardial strain). The oximetric technique always relies on the assumption of similar 
oxygen uptake and consumption and that the relation between the oxygen saturation in the inferior and superior 
caval vein is constant. This study only looked at shunt estimations in simple intracardiac shunts (ASD and/or VSD 
defects). It remains to be seen how well COstatus performs in patients with more complex mixing lesions (e.g. 
single ventricles). The final limitation is that the arterial line was not available for continuous arterial pressure 
monitoring during COstatus measurement sessions.
The strength of this study is the high number of homogenous younger patients compared to that of previous 
hemodynamic pediatric studies and that measurements were performed simultaneously with all methods within 
a very narrow time period.
The technology of the COstatus monitor is less invasive compared to previous cardiac output reference meth-
ods (e.g. cardiac catheterization, thermodilution, perivascular flow probes and the Fick method) and is highly 
sensitive and specific regarding detection and estimation of left-to-right shunts (an extra feature not available in 
earlier bedside hemodynamic monitors). It is easily applied in young children with less technical limitations, as it 
only requires a central and an arterial line (often in place in critically ill patients), uses body-temperature saline 
as an indicator in small amounts, involves no blood loss and does not require invasive control of ventilation or 
sedation/anesthesia when catheters are in place. COstatus has performed well in pediatric cardiac output compar-
ison studies and could help bridge the gap between invasive hemodynamic monitors and non-invasive methods 
in the future12,25–27. In our opinion, the COstatus monitor is not a technique that can replace echocardiography 
in the evaluation and the clinical decision-making regarding need for cardiac intervention. However, used in 
combination with echocardiography, it adds to important information regarding general hemodynamic status in 
patients, including cardiac output.
To summarize, the COstatus monitoring device detected intracardiac shunts with high sensitivity and speci-
ficity, but was not superior to echocardiography. There was some underestimation of shunt ratios with COstatus 
compared with the reference techniques.
Methods
patient and data collection. Patients enrolled in this study were part of a cohort of patients undergoing 
elective cardiac surgery for the correction of an atrial septal defect (ASD) and/or a ventricular septal defect (VSD). 
The inclusion criteria included informed written parental consent, weight <15 kg, and ASD and/or VSD defect. 
Children with conditions that influenced the stability of the measurements, such as perioperative arrythmias and/
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or valvular regurgitations, were excluded. The study was approved by the Ethics Committee of Lund University, 
Sweden (Dnr 2013636).
experimental protocol. Anesthesia was induced using fentanyl (5 mcg/kg) and penthothal (5 mg/kg) and 
maintained with isoflurane (0.5–1.0%). Pancuronium (0.2 mg/kg) was given to facilitate intubation with a cuffed 
endotracheal tube. All children received a peripheral arterial catheter in the radial artery (Neoflow 24 G in <5 kg 
patients and Venflow 22 G in >5 kg patients; BD Ltd, Wokingham, UK) and a central venous catheter (Multicath 
triple lumen 6 cm, 4.5 F; Vygon Ltd, Swindon, UK) in the right internal jugular vein. The COstatus AV loop was 
connected to the arterial catheter and to the distal lumen of the central venous catheter. The AV loop was primed 
with heparinized (2 units/ml) normothermic isotonic saline. COstatus ultrasound sensors were placed on the 
arterial and venous sides of the AV loop. A preoperative transesophageal echocardiography (TEE) was performed 
to determine cardiac function and existing defects. Prior to cardiopulmonary bypass, the surgeon placed perivas-
cular flow probes consecutively around the ascending aorta and then the pulmonary truncus. The size of the 
probes made it impossible to fit them both simultaneously without compromising the circulation. Five consecu-
tive measurements were performed of ascending aortic blood flow simultaneously with five measurements with 
COstatus. This was immediately followed by five consecutive measurements of pulmonary blood flow. Thereafter, 
the surgeon took blood samples from the pulmonary truncus, inferior vena cava (IVC), and superior vena cava 
(SVC) by direct puncture. An arterial blood sample was simultaneously taken from the arterial catheter, and the 
Qp/Qs ratio was calculated by the oximetric shunt formula. The fraction of inspiratory oxygen was kept at 0.3–0.4 
to ensure full arterial oxygen saturation and, therefore, fully saturated blood in the left atrium. After the surgical 
correction, the measurements were repeated in the same order. The surgical result was controlled by a postoper-
ative TEE investigation by a cardiologist who was blinded to the other findings.
The algorithm in COstatus estimates a Qp/Qs ratio in every patient. Transonic has chosen to present it as a 
range value in accordance with clinical significance. The children were thus categorized into five different groups 
of Qp/Qs ratios (Table 1).
Shunt measurements. COstatus®. The COstatus monitor device (Transonic Systems Inc., Ithaca, NY, 
USA) uses a specific single-use extracorporeal arteriovenous circuit (AV-loop), which is connected to the arte-
rial and central venous catheters already in place (Fig. 3A). External ultrasound sensors are then attached to 
the AV loop to detect the level of blood dilution (Fig. 3B). A roller-pump connected to the AV-loop guarantees 
a constant blood flow rate of 9–12 ml/min. A determined volume (0.5–1.0 ml/kg) of isotonic saline, warmed to 
body temperature, is injected into a venous port near the venous ultrasound sensor, which is connected to the 
AV-loop (Fig. 3C). As blood and saline have different ultrasound velocities (blood has an ultrasound velocity of 
1.560–1.585 m/s and saline 1.530 m/s), there will be a reduction in ultrasound velocity when saline is added to 
the circulation. This change in ultrasound velocity (sometimes called ultrasound dilution) can then be used to 
estimate cardiac output and other hemodynamic parameters (just as temperature changes are used to estimate 
cardiac output in thermodilution). Venous ultrasound sensors measure the ultrasound velocity of blood when it 
passes through the venous part of the AV loop just before entering the circulation via the central venous catheter. 
Then, in turn, the arterial ultrasound sensor connected to the arterial part of the AV-loop detects changes in the 
ultrasound velocity of the blood as it exits the arterial line after transcardiopulmonary passage. This transient 
decrease in ultrasound velocity produces both a venous and arterial dilution curve that are then compared and 
analyzed by the COstatus monitor (Fig. 3D). The systemic dilution of the injected volume of saline is then used to 
calculate the ejected cardiac output by modifying the Stewart-Hamilton equation28–30. In a normal heart without 
intracardiac shunts, an undistorted and almost symmetric dilution curve is detected by the arterial sensor. Then, 
the diluted blood returns to the arterial sensor after a second systemic recirculation. This is recognized by a sec-
ond lower bump occurring later in the arterial dilution curve trace in a biventricular circulation without shunt 
defects. This systemic recirculation is rapid in children and may complicate shunt detection. In the presence of 
a left-to-right intracardiac shunt, the diluted blood reenters the pulmonary circulation through the defect. This 
results in a delay of a full flush of the saline from the cardiopulmonary system and is observed in the descent of 
the declining limb of the arterial dilution curve (Fig. 4). The delay in the declining part of the curve depends on 
the amount of shunted blood that recirculates. In defects with a large shunt, the amount of blood that reenters the 
pulmonary circulation may be so substantial that it merges with the diluted blood that reappears after the second 
systemic recirculation. This will affect the downward slope of the declining limb and the total curve area, which 
makes an adequate calculation of the Qp/Qs ratio difficult.
Using an imaginary vertical line from the peak dilution (peak change in ultrasound velocity) to the base, the 
symmetry or asymmetry of the descending part can be detected at the half peak level, by comparing the distance 
between the vertical line and the ascending curve line (a) and between the vertical line and the descending curve 
line (b) (Fig. 4). According to research data, the a:b ratio in a four-chambered heart without a shunt is approx-
imately 1.4 ± 0.13 (or ±13%). This variation is associated with factors such as the rate of injection, accuracy of 
the algorithm to calculate area, and other hemodynamic factors that can cause asymmetry in the dilution curve 
besides shunts. Since the ascending part of the curve reflects the dilution without pulmonary recirculation, it 
can be used to construct an almost similar imaginary descending curve with a delay less than 1:1.4. The area 
under that imaginary curve (AUC) and the Stewart-Hamilton principle can then be used to calculate a plausible 
normal blood flow without recirculation. Then, the AUC and the Stewart-Hamilton principle can be used to 
calculate the blood flow beneath the actual curve containing the recirculated blood flow corresponding to the 
delayed descending curve. The difference between these curves corresponds to the shunt recirculation leading 
to a calculation of the Qp/Qs ≈ (b/a)/1.4 ± 13% displayed on the screen (Fig. 4B). In our data analysis, COstatus 
was considered to have identified a shunt if we observed the screen message (Fig. 3D) in at least 2 out of the 5 
consecutive measurements.
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perivascular flow probes (pVfp). Perivascular ultrasonic transit-time flow probes, COnfidence, 
AU-series (Transonic Systems Inc., Ithaca, NY, USA) were positioned around the pulmonary truncus and around 
the ascending aorta distal to the branch of the coronary arteries. These flow probes were custom designed (avail-
able in different diameter sizes) to fit around vessels to measure real-time blood flow. The flow probes come 
pre-calibrated from the manufacturer, with a certified length of use for more than one year and can be used mul-
tiple times as they tolerate standard sterilization. When the flow probes had been placed correctly, they were con-
nected to Optima dual channel Flow-Qc meter, model HT364 (Transonic Systems Inc, Ithaca, NY, USA) and the 
diagnostic software AureFlo (Transonic Systems Inc, Ithaca, NY, USA), which provides a graphic display of the 
blood flow. By comparing blood flow in the pulmonary truncus (Qp) and ascending aorta (Qs), the shunt ratio 
can be calculated by dividing Qp with Qs (Qp/Qs) (Fig. 5). Transit-time technology has been used and validated 
in earlier studies and is now considered an established reference method for cardiac output16,31,32.
oximetric shunt equation (oSe). In patients with left-to-right shunts, the oximetric shunt equation can 
be used to estimate the ratio between pulmonary blood flow (Qp) and systemic blood flow (Qs), Qp/Qs. By 
assuming that the oxygen uptake (VO2) in Eq. 1 is similar to the oxygen consumption (VO2) in Eq. 2, the shunt 
fraction Qp/Qs can be derived from Eq. 3. (CaO2 = content of oxygen in arterial blood, CmvO2 = content of 
oxygen in venous blood (by Flamm’s formula (3SVC + IVC)/4), CpvO2 = content of oxygen in pulmonary venous 
blood, and CpaO2 = content of oxygen in pulmonary arterial blood.
Figure 3. (A) Schematic picture of COstatus monitor and AV loop setup connected to a patient, (B) placement 
of venous ultrasound probe on AV loop, (C) injection of saline bolus into the AV loop, and (D) arterial dilution 
curve screen display showing a possible shunt.
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In this study, blood gas analysis was performed with the ABL800 Flex Radiometer (Radiometer AS, Brønshøj, 
Denmark). The pulmonary venous oxygen saturation was expected to be full since the arterial oxygen saturation 
was 97–100%.
transesophageal echocardiography. A Philips S8–3T pediatric transesophageal echocardiography 
transducer probe was used in this study with a Philips iE33 ultrasound system (Philips Healthcare, Andover, MA, 
USA) for pre- and postoperative evaluation of cardiac function. Conventional cross-sectional echocardiography 
and doppler color flow were used to detect the defects. The size of the defect was estimated and categorized as 
follows:
Very small: if there was only a narrow jet of flow detected by the color flow Doppler.
Small: if there was a wider jet on the color flow doppler and the defect could be visualized on 2D imaging.
Moderate to Large: if the flow was clearly visualized by the color flow doppler, the defect could be visualized on 
2D imaging, and there were visual signs of right cardiac chamber overload.
Figure 4. The effect of a left-to-right intracardiac shunt observed in the arterial curve. One part of the injected 
indicator (saline) passes normally through the cardiopulmonary system and exits into the aorta. The second 
part recirculates multiple times through the pulmonary system (gray area) until all indicators exit the heart. 
This delay is observed in the descending part of the arterial dilution curve. (A) Normal dilution curve without 
intracardiac shunt, (B) Small intracardiac left-to right shunt, (C) Moderate intracardiac left-to-right shunt and 
(D) Large left-to-right intracardiac shunt. By analyzing the distance between an imaginary vertical line from 
peak dilution and the ascending dilution curve (a) and the descending dilution curve (b) at the half peak level, 
an asymmetry can be detected indicating the presence of a possible left-to-right shunt. (Pictures are adapted 
from the Shunts Modeling program, Transonic Systems Inc.).
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Statistical analysis. The statistical power analysis was performed for sample size estimation based on data 
from an earlier pilot study comparing Qp/Qs ratios (14). In that study, the bias was 0.4, and the pooled SD was 
0.7, resulting in an effect size of 0.57. G-Power 3.1.9.3 software (Kiel University, Germany) was used for power 
calculations. To reject the null hypothesis, the sample size for this study with an alpha error of p 0.05 and power 
of 0.90 needed to be at least n = 28. The final number of patients was related to the fact that a higher number of 
patients was needed for a simultaneous cardiac output comparison study25.
Histograms and Shapiro-Wilk test were used to confirm normal distribution of the data.
Analysis of variance (ANOVA) was used to detect statistical significance between the three different tech-
niques used to determine Qp/Qs ratios. The bias between Qp/Qs ratios by the perivascular flow probes (Qp/
Qs PVFP) and the oximetric saturation data (Qp/Qs OSE) was analyzed according to the Bland-Altman method, 
accounting for multiple measurements per individual33,34. The mean difference (bias) was calculated and plotted 
against the average of the comparison. The 95% limits of agreement (LOA) were calculated as the mean bias of 
1.96* ± SD (standard deviation of the difference between methods). The percentage error (PE) was calculated 
using the following equation:
Figure 5. Optima dual channel Flow-Qc meter, model HT364 and a schematic explanation of how the invasive 
COnfidence ultrasound flow probes were used to compare differences in blood flow in both pulmonary truncus 
(Qp) and ascending aorta (Qs) to estimate the shunt ratio (Qp/Qs). (A) Exposure of the heart through an open 
sternotomy, (B) placement of flow probe on the great arteries for blood flow measurements, and (C) in-theatre 
setup for the diagnostic AureFlow monitor and Optima flow meter. (Photos of flow probes and flow meter 
adapted with permission of Transonic Systems Inc.).
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Statistica version 13 (Dell Inc., Tulsa, OK, USA) was used for statistical analysis, and all data are expressed as 
the mean ± standard deviation (SD) unless otherwise indicated.
ethical standards. This study was approved by the Ethics Committee of Lund University, Sweden, and was 
in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
informed consent. Written informed consent was obtained from the parents of all patients.
Received: 31 May 2019; Accepted: 14 January 2020;
Published online: 28 January 2020
References
 1. Tibby, S. M., Hatherill, M., Marsh, M. J. & Murdoch, I. A. Clinicians’ abilities to estimate cardiac index in ventilated children and 
infants. Arch. Dis. Childhood. 77, 516–518 (1997).
 2. Egan, J. R. et al. Clinical assessment of cardiac performance in infants and children following cardiac surgery. Intensive Care Med. 
31, 568–573 (2005).
 3. Lemson, J., Nusmeier, A. & van der Hoeven, J. G. Advanced hemodynamic monitoring in critically ill children. Pediatrics. 128, 
560–571 (2011).
 4. Skowno, J. J. & Broadhead, M. Cardiac output measurement in pediatric anesthesia. Paediatr. Anaesth. 18, 1019–1028 (2008).
 5. de Boode, W. P. Cardiac output monitoring in newborns. Early Hum. Dev. 86, 143–148 (2010).
 6. Shephard, J., Brecker, S. & Ewans, T. Bedside assessment of myocardial performance in the critically ill. Intensive Care Med. 20, 
513–521 (1994).
 7. Le Manach, Y. & Collins, G. S. Disagreement between cardiac output measurement devices: which device is the gold standard? Br. J. 
Anaesth. 116, 451–453 (2016).
 8. Suehiro, K. et al. Accuracy and precision of minimally-invasive cardiac output monitoring in children: a systematic review and 
meta-analysis. J. Clin. Monit. Comput. 30, 603–620 (2016).
 9. Stark, R. J. & Shekerdemian, L. S. Estimating intracardiac and extracardiac shunting in the setting of complex congenital heart 
disease. Ann. Pediatr. Cardiol. 6, 145–151 (2013).
 10. Peyton, P. J. & Chong, S. W. Minimally invasive measurement of cardiac output during surgery and critical Care: a meta-analysis of 
accuracy and precision. Anesthesiology. 113, 1220–1235 (2010).
 11. Krivitski, N. M., Kislukhin, V. V. & Thuramalla, N. V. Theory and in vitro validation of a new extracorporeal arteriovenous loop 
approach for hemodynamic assessment in pediatric and neonatal intensive care unit patients. Pediatr. Crit. Care Med. 9, 423–428 
(2008).
 12. Crittendon, I., Dreyer, W. J., Decker, J. A. & Kim, J. J. Ultrasound dilution: an accurate means of determining cardiac output in 
children. Pediatr. Crit. Care Med. 13, 42–46 (2012).
 13. Vrancken, S. L. et al. Influence of lung injury on cardiac output measurement using transpulmonary ultrasound dilution: a validation 
study in neonatal lambs. Br. J. Anaesth. 109, 870–878 (2012).
 14. Lindberg, L., Johansson, S. & Perez-de-Sa, V. Validation of an ultrasound dilution technology for cardiac output measurement and 
shunt detection in infants and children. Pediatr. Crit. Care Med. 15, 139–147 (2014).
 15. Saxena, R. et al. Accuracy of the transpulmonary ultrasound dilution method for detection of small anatomic shunts. J. Clin. Monit. 
Comput. 29, 407–414 (2015).
 16. Vrancken, S. L. et al. Cardiac output measurement with transpulmonary ultrasound dilution is feasible in the presence of a left-to-
right shunt: a validation study in lambs. Br. J. Anaesth. 108, 409–416 (2012).
 17. Vrancken, S. L. et al. Hemodynamic volumetry using transpulmonary ultrasound dilution (TPUD) technology in a neonatal animal 
model. J. Clin. Monit. Comput. 29, 643–652 (2015).
 18. Boehne, M. et al. Novel ultrasound dilution technique detects left-to-right shunts with high accuracy in children. The 3rd Congress 
of European Academy of Paediatric Societies (EAPS), Copenhagen, Denmark; Poster 1680 (2010).
 19. Shia, A. et al. Saline ultrasound dilution technique as a minimally invasive way to detect intracardiac shunt in an atrial septal defect 
model. Crit. Care Med. 39(Supplement), P61 (2011).
 20. Krovetz, L. & Gessner, I. A new method utilizing indicator dilution technics for estimation of left-to-right shunts in infants. 
Circulation. 32, 772–777 (1965).
 21. Mook, G. & Zijlstra, W. Quantitative evaluation of intracardiac shunt from arterial dye dilution curves. Demonstration of very small 
shunts. Acta Med. Scand. 170, 703–715 (1961).
 22. Hetzl, P., Swan, H. & Wood, E. Quantitative estimation by indicator dilution techniques of the contribution of blood from each lung 
to the left-to-right shunt in atrial septal defect. Circulation. 14, 212–220 (1956).
 23. Ramirez de Arellano, A., Hetzel, P. & Wood, E. Measurement of pulmonary blood flow using the indicator dilution techniques in 
patients with a central arteriovenous shunt. Circ. Res. 4, 400–405 (1956).
 24. Daniel, W. C. et al. Oximetric versus indicator dilution techniques for quantitating intracardiac left-to-right shunting in adults. Am. 
J. Cardiology. 75, 199–200 (1995).
 25. Sigurdsson, T. S., Aronsson, A. & Lindberg, L. Extracorporeal arteriovenous ultrasound measurement of cardiac output in small 
children. Anesthesiology. 130, 712–718 (2019).
 26. Trieu, C. T., Williams, T. M., Cannesson, M. & Marijic, J. Babies and children at last: Pediatric cardiac output monitoring in the 
twenty-first century. Anesthesiology. 130, 671–673 (2019).
 27. Boehne, M. et al. Determination of cardiac output by ultrasound dilution technique in infants and children: a validation study 
against direct Fick principle. Br. J. Anaesth. 112, 469–476 (2014).
 28. Stewart, G. Researches on the circulation time and on the influences which affect it. J. Physiology. 22, 159–183 (1897).
 29. Hamilton, W. F., Moore, J. W., Kinsman, J. M. & Spurling, R. G. Studies on the circulation. Am. J. Physiology. 99, 534–551 (1932).
 30. Reuter, D. A. et al. Cardiac output monitoring using indicator-dilution techniques: basics, limits, and perspectives. Anesth. Analg. 
110, 799–811 (2010).
 31. Dean, D. A., Jia, C. X. & Cabreriza, S. E. Validation study of a new transit time ultrasonic flow probe for continuous great vessel 
measurements. ASAIO J. 42, M671–676 (1996).
 32. Botero, M. et al. Measurement of cardiac output before and after cardiopulmonary bypass: Comparison among aortic transit-time 
ultrasound, thermodilution, and noninvasive partial CO2 rebreathing. J. Cardiothorac. Vasc. Anesthesia. 18, 563–572 (2004).
1 0Scientific RepoRtS | (2020) 10:1337 | https://doi.org/10.1038/s41598-020-58347-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
 33. Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 8, 
307–310 (1986).
 34. Zou, G. Y. Confidence interval estimation for the Bland-Altman limits of agreement with multiple observations per individual. Stat. 
Methods Med. Res. 22, 630–642 (2013).
Acknowledgements
Thanks to our pediatric cardiac surgical team at Lund Children’s Hospital (Lund, Sweden) for their help, patience 
and understanding and to Nikolai Krivitski PhD, DSc, senior scientist from Transonic, for technical assistance. 
This work was supported by a project grant from The Swedish Children Heart Association (Stockholm, Sweden) 
and The Anna & Edwin Bergers private foundation (Lidingö, Sweden). Open access funding provided by Lund 
University.
Author contributions
T.S.S. and L.L. designed the study, performed all measurements, conducted the statistical analysis and wrote the 
manuscript. T.S.S. registered all data and prepared all figures. L.L. did the last revision of the manuscript.
competing interests
The authors declare no competing interests.
Additional information
Correspondence and requests for materials should be addressed to T.S.S.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
